Allspring Global Investments
ZYME icon

Allspring Global Investments’s Zymeworks ZYME Stock Holding History

Allspring Global Investments’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$221K Buy
8,507
+800
+10% +$18.9K ﹤0.01% 1586
2025
Q4 		$205K Buy
+7,707
New +$168K ﹤0.01% 1575
2024
Q4 		– Sell
-696
Closed -$8.73K – 2453
2024
Q3 		$8.73K Hold
696
– – ﹤0.01% 2107
2024
Q2 		$5.92K Sell
696
-142,519
-100% -$1.27M ﹤0.01% 2219
2024
Q1 		$1.51M Sell
143,215
-84,410
-37% -$937K ﹤0.01% 1263
2023
Q4 		$2.37M Buy
227,625
+38,181
+20% +$304K ﹤0.01% 1134
2023
Q3 		$1.2M Buy
189,444
+148,212
+359% +$1.09M ﹤0.01% 1322
2023
Q2 		$356K Buy
41,232
+2,187
+6% +$19.6K ﹤0.01% 1640
2023
Q1 		$353K Buy
39,045
+746
+2% +$6.5K ﹤0.01% 1674
2022
Q4 		$301K Sell
38,299
-5,628
-13% -$39.5K ﹤0.01% 1732
2022
Q3 		$270K Buy
43,927
+21,407
+95% +$129K ﹤0.01% 1733
2022
Q2 		$119K Buy
22,520
+4,226
+23% +$25.6K ﹤0.01% 1999
2022
Q1 		$119K Hold
18,294
– – ﹤0.01% 2713
2021
Q4 		$299K Buy
+18,294
New +$381K ﹤0.01% 2514

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Allspring Global Investments's ZYME Position: Q1 2026 in Review

Allspring Global Investments increased its Zymeworks (ZYME) stake by 10% in Q1 2026, buying an estimated $18.9K and bringing the position to 8,507 shares worth $221K. The position accounts for ﹤0.01% of the portfolio, ranked #1586.

Allspring Global Investments first reported a position in ZYME in Q4 2021 and has held it in 14 quarters since. The position peaked at $2.37M in Q4 2023. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Allspring Global Investments held 8,507 shares of Zymeworks worth $221K as of Q1 2026.
  • Allspring Global Investments bought 800 Zymeworks shares in Q1 2026, an estimated $18.9K.
  • Zymeworks made up ﹤0.01% of Allspring Global Investments's portfolio in Q1 2026, its #1586 holding.
  • Allspring Global Investments first reported a position in Zymeworks in Q4 2021 and has held it in 14 quarters since.
  • Allspring Global Investments's Zymeworks position peaked at $2.37M in Q4 2023.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.